Literature DB >> 10696426

Molecular characteristics of very virulent European MDV isolates.

A Barrow1, K Venugopal.   

Abstract

Marek's disease virus (MDV) strains with increasing virulence have been reported from many parts of the world. Many of these recent MDV isolates produce an acute early cytolytic disease with high mortality and severe atrophy of the lymphoid organs, thymus and the bursa of Fabricius. Although the degree of the atrophic changes and the virulence of the virus are correlated, the molecular basis of the increased virulence is not known. We examined the characteristics of the disease induced by 3 such MDV isolates, C12/130, MR36 and MR48, isolated from Europe. All the three viruses produce high early mortality and atrophy of the lymphoid organs. As a first step in understanding the determinants of the increased virulence of these isolates, we have compared the sequences of MEQ and the ICP4 genes of these three viruses with that of the published sequences. Some of the amino acid changes seen within the Meq and ICP4 proteins were conserved in all the three isolates and could account for the increased virulence characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10696426

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  8 in total

1.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Authors:  Yan-Ping Zhang; Hong-Chao Lv; Ke-Yan Bao; Yu-Long Gao; Hong-Lei Gao; Xiao- le Qi; Hong-Yu Cui; Yong-Qiang Wang; Kai Li; Li Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2015-11-26       Impact factor: 2.332

3.  Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.

Authors:  Stephen J Spatz; Jeremy D Volkening; Isabel M Gimeno; Mohammad Heidari; Richard L Witter
Journal:  Virus Genes       Date:  2012-08-26       Impact factor: 2.332

4.  Pathogenicity of a very virulent strain of Marek's disease herpesvirus cloned as infectious bacterial artificial chromosomes.

Authors:  Lorraine P Smith; Lawrence J Petherbridge; Susan J Baigent; Jennifer Simpson; Venugopal Nair
Journal:  J Biomed Biotechnol       Date:  2010-11-25

5.  Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy.

Authors:  Guo-Rong Sun; Yan-Ping Zhang; Lin-Yi Zhou; Hong-Chao Lv; Feng Zhang; Kai Li; Yu-Long Gao; Xiao-Le Qi; Hong-Yu Cui; Yong-Qiang Wang; Li Gao; Qing Pan; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Viruses       Date:  2017-06-21       Impact factor: 5.048

6.  Isolation and purification of Gallid herpesvirus 2 strains currently distributed in Japan.

Authors:  Yuka Machida; Shiro Murata; Ayumi Matsuyama-Kato; Masayoshi Isezaki; Akira Taneno; Eishi Sakai; Satoru Konnai; Kazuhiko Ohashi
Journal:  J Vet Med Sci       Date:  2016-10-08       Impact factor: 1.267

7.  Genetic characterization of a Marek's disease virus strain isolated in Japan.

Authors:  Shiro Murata; Yuka Machida; Masayoshi Isezaki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Journal:  Virol J       Date:  2020-11-23       Impact factor: 4.099

8.  Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.

Authors:  Susan J Baigent; Venugopal K Nair; Hervé Le Galludec
Journal:  J Virol Methods       Date:  2016-03-10       Impact factor: 2.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.